Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier

Naohiko Shimada, Ken J. Ishii, Yoichi Takeda, Cevayir Coban, Yuichi Torii, Seiji Shinkai, Shizuo Akira, Kazuo Sakurai

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Oligodeoxynucleotides containing unmethylated CpG sequences (CpG DNAs) are known as an immune adjuvant. CpG DNAs coupled with a particular antigen enabling both CpG DNA and antigen delivery to the same antigen-presenting cell have been shown to be more effective. Based on our previous finding that β-(1→3)-D-glucan schizophyllan (SPG) can be used as a CpG DNA carrier, here we present the synthesis of an antigen-conjugated SPG and the characterization of the conjugate. Ovalbumin (OVA, 43 kDa) was used as a model antigen, and two OVA were conjugated to one SPG molecule (M w = 150 000), denoted by OVA-SPG. Circular dichroism and gel electrophoresis showed that OVA-SPG could form a complex with a (dA) 40-tailed CpG DNA at the 3′ end (1668-(dA) 40). When OVA-SPG was added to macrophages (J774.A1), the amount of the ingested OVA-SPG was increased compared with that of OVA itself, suggesting that Dectin-1 (proinflammatory nonopsonic receptor for β-glucans) is involved to ingest OVA-SPG. Furthermore, the complex of the conjugate and DNA was co-localized in the same vesicles, implying that OVA (antigen) and CpG DNA (adjuvant) were ingested into the cell at the same time. This paper shows that OVA-SPG can be used as a CpG DNA carrier to induce antigen-specific immune responses.

Original languageEnglish
Pages (from-to)1136-1140
Number of pages5
JournalBioconjugate Chemistry
Volume17
Issue number5
DOIs
Publication statusPublished - Sep 1 2006

Fingerprint

Antigens
Polysaccharides
DNA
Sizofiran
Glucans
Macrophages
Oligodeoxyribonucleotides
DNA sequences
Histocompatibility Antigens Class II
Ovalbumin
Dichroism
Antigen-Presenting Cells
Circular Dichroism
In Vitro Techniques
Electrophoresis
Gels
Molecules

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Cite this

Shimada, N., Ishii, K. J., Takeda, Y., Coban, C., Torii, Y., Shinkai, S., ... Sakurai, K. (2006). Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier. Bioconjugate Chemistry, 17(5), 1136-1140. https://doi.org/10.1021/bc060070g

Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier. / Shimada, Naohiko; Ishii, Ken J.; Takeda, Yoichi; Coban, Cevayir; Torii, Yuichi; Shinkai, Seiji; Akira, Shizuo; Sakurai, Kazuo.

In: Bioconjugate Chemistry, Vol. 17, No. 5, 01.09.2006, p. 1136-1140.

Research output: Contribution to journalArticle

Shimada, N, Ishii, KJ, Takeda, Y, Coban, C, Torii, Y, Shinkai, S, Akira, S & Sakurai, K 2006, 'Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier', Bioconjugate Chemistry, vol. 17, no. 5, pp. 1136-1140. https://doi.org/10.1021/bc060070g
Shimada, Naohiko ; Ishii, Ken J. ; Takeda, Yoichi ; Coban, Cevayir ; Torii, Yuichi ; Shinkai, Seiji ; Akira, Shizuo ; Sakurai, Kazuo. / Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier. In: Bioconjugate Chemistry. 2006 ; Vol. 17, No. 5. pp. 1136-1140.
@article{c6ee709b71cb490f80ce6d7a9b9f577a,
title = "Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier",
abstract = "Oligodeoxynucleotides containing unmethylated CpG sequences (CpG DNAs) are known as an immune adjuvant. CpG DNAs coupled with a particular antigen enabling both CpG DNA and antigen delivery to the same antigen-presenting cell have been shown to be more effective. Based on our previous finding that β-(1→3)-D-glucan schizophyllan (SPG) can be used as a CpG DNA carrier, here we present the synthesis of an antigen-conjugated SPG and the characterization of the conjugate. Ovalbumin (OVA, 43 kDa) was used as a model antigen, and two OVA were conjugated to one SPG molecule (M w = 150 000), denoted by OVA-SPG. Circular dichroism and gel electrophoresis showed that OVA-SPG could form a complex with a (dA) 40-tailed CpG DNA at the 3′ end (1668-(dA) 40). When OVA-SPG was added to macrophages (J774.A1), the amount of the ingested OVA-SPG was increased compared with that of OVA itself, suggesting that Dectin-1 (proinflammatory nonopsonic receptor for β-glucans) is involved to ingest OVA-SPG. Furthermore, the complex of the conjugate and DNA was co-localized in the same vesicles, implying that OVA (antigen) and CpG DNA (adjuvant) were ingested into the cell at the same time. This paper shows that OVA-SPG can be used as a CpG DNA carrier to induce antigen-specific immune responses.",
author = "Naohiko Shimada and Ishii, {Ken J.} and Yoichi Takeda and Cevayir Coban and Yuichi Torii and Seiji Shinkai and Shizuo Akira and Kazuo Sakurai",
year = "2006",
month = "9",
day = "1",
doi = "10.1021/bc060070g",
language = "English",
volume = "17",
pages = "1136--1140",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier

AU - Shimada, Naohiko

AU - Ishii, Ken J.

AU - Takeda, Yoichi

AU - Coban, Cevayir

AU - Torii, Yuichi

AU - Shinkai, Seiji

AU - Akira, Shizuo

AU - Sakurai, Kazuo

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Oligodeoxynucleotides containing unmethylated CpG sequences (CpG DNAs) are known as an immune adjuvant. CpG DNAs coupled with a particular antigen enabling both CpG DNA and antigen delivery to the same antigen-presenting cell have been shown to be more effective. Based on our previous finding that β-(1→3)-D-glucan schizophyllan (SPG) can be used as a CpG DNA carrier, here we present the synthesis of an antigen-conjugated SPG and the characterization of the conjugate. Ovalbumin (OVA, 43 kDa) was used as a model antigen, and two OVA were conjugated to one SPG molecule (M w = 150 000), denoted by OVA-SPG. Circular dichroism and gel electrophoresis showed that OVA-SPG could form a complex with a (dA) 40-tailed CpG DNA at the 3′ end (1668-(dA) 40). When OVA-SPG was added to macrophages (J774.A1), the amount of the ingested OVA-SPG was increased compared with that of OVA itself, suggesting that Dectin-1 (proinflammatory nonopsonic receptor for β-glucans) is involved to ingest OVA-SPG. Furthermore, the complex of the conjugate and DNA was co-localized in the same vesicles, implying that OVA (antigen) and CpG DNA (adjuvant) were ingested into the cell at the same time. This paper shows that OVA-SPG can be used as a CpG DNA carrier to induce antigen-specific immune responses.

AB - Oligodeoxynucleotides containing unmethylated CpG sequences (CpG DNAs) are known as an immune adjuvant. CpG DNAs coupled with a particular antigen enabling both CpG DNA and antigen delivery to the same antigen-presenting cell have been shown to be more effective. Based on our previous finding that β-(1→3)-D-glucan schizophyllan (SPG) can be used as a CpG DNA carrier, here we present the synthesis of an antigen-conjugated SPG and the characterization of the conjugate. Ovalbumin (OVA, 43 kDa) was used as a model antigen, and two OVA were conjugated to one SPG molecule (M w = 150 000), denoted by OVA-SPG. Circular dichroism and gel electrophoresis showed that OVA-SPG could form a complex with a (dA) 40-tailed CpG DNA at the 3′ end (1668-(dA) 40). When OVA-SPG was added to macrophages (J774.A1), the amount of the ingested OVA-SPG was increased compared with that of OVA itself, suggesting that Dectin-1 (proinflammatory nonopsonic receptor for β-glucans) is involved to ingest OVA-SPG. Furthermore, the complex of the conjugate and DNA was co-localized in the same vesicles, implying that OVA (antigen) and CpG DNA (adjuvant) were ingested into the cell at the same time. This paper shows that OVA-SPG can be used as a CpG DNA carrier to induce antigen-specific immune responses.

UR - http://www.scopus.com/inward/record.url?scp=33749036876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749036876&partnerID=8YFLogxK

U2 - 10.1021/bc060070g

DO - 10.1021/bc060070g

M3 - Article

C2 - 16984120

AN - SCOPUS:33749036876

VL - 17

SP - 1136

EP - 1140

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 5

ER -